Common Contracts
7 similar Placement Agency Agreement contracts by Jaguar Health, Inc., AMEDICA Corp, Auris Medical Holding AG, others
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 30th, 2021 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 25th, 2019 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 15th, 2019 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 3rd, 2018 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • January 30th, 2018 • Auris Medical Holding AG • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 8th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 8th, 2015 • AMEDICA Corp • Surgical & medical instruments & apparatus • New York
Introduction. Subject to the terms and conditions herein (this “Agreement”), Amedica Corporation, a Delaware corporation (the “Company”), hereby agrees to sell up to an aggregate of $15,000,000 of registered and unregistered securities (the “Securities”) of the Company, including, but not limited to, shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the "Common Stock”) and common stock purchase warrants (the “Warrants” and, together with the Shares and the Common Stock underlying the Warrants, the “Securities”) directly to various investors (each, an “Investor” and, collectively, the “Investors”) through Ladenburg Thalmann & Co. Inc., as placement agent (“Ladenburg” or the “Placement Agent”). The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Offering (as defined below).
